Signal therapy of NF1-deficient tumor xenograft in mice by the anti-PAK1 drug FK228

Research output: Contribution to journal › Article › peer-review

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

@article{e161594b55de4d74a823aaa204500ebe,

title = "Signal therapy of NF1-deficient tumor xenograft in mice by the anti-PAK1 drug FK228",

keywords = "FK228, PAK1, NF1, neurofibromatosis",

author = "Y Hirokowa and H Nakajima and CO Hanemann and A Kurtz and S Frahm and V Mautner and H Maruta",

year = "2005",

language = "English",

volume = "4",

pages = "379--381",

journal = "CANCER BIOLOGY \& THERAPY",

issn = "1538-4047",

publisher = "Taylor and Francis Ltd.",

number = "4",

}

TY - JOUR

T1 - Signal therapy of NF1-deficient tumor xenograft in mice by the anti-PAK1 drug FK228

AU - Hirokowa, Y

AU - Nakajima, H

AU - Hanemann, CO

AU - Kurtz, A

AU - Frahm, S

AU - Mautner, V

AU - Maruta, H

PY - 2005

Y1 - 2005

KW - FK228

KW - PAK1

KW - NF1

KW - neurofibromatosis

M3 - Article

SN - 1538-4047

VL - 4

SP - 379

EP - 381

JO - CANCER BIOLOGY & THERAPY

JF - CANCER BIOLOGY & THERAPY

IS - 4

ER -